LEUVEN, Belgium, July 17, 2024 /PRNewswire/ — P95 BV (“P95”), an Ampersand Capital Partners portfolio company, is proud to announce the appointment of Laurence De Moerlooze as Chief Medical Officer (CMO). Laurence will provide medical leadership and spearhead operational oversight across…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.